A large, rare disease global biopharmaceutical company that is dedicated to finding solutions to help patients living with rare diseases implements additional RxLogix PV systems

15 Apr 2022

It was a large project that included the following key systems and capabilities:

• PV Quality – New system implementation to monitor the PV case quality
• PV Reports Upgrade
  • Implementation of Reporting Rate calculations in disproportionality algorithms based on imported drug sales/patient exposure data
  • EVDAS auto-download utility
• PV Reports Japan – Two new reports (NUPR, SLL)
• Tech: Upgrade of Oracle 12C to Oracle 19C